Octreotide subcutaneous depot for acromegaly: A randomized, double-blind, placebo-controlled phase 3 trial, ACROINNOVA 1

Ferone, D., Freda, P., Katznelson, L., Gatto, F., Kadioğlu, P., Maffei, P., Seufert, J., Silverstein, J. M., Spencer-Segal, J. L., Isaeva, E., Dreval, A., Harrie, M., Svedberg, A., & Tiberg, F. (2024). Octreotide Subcutaneous Depot for Acromegaly: A Randomized, Double-blind, Placebo-controlled Phase 3 Trial, ACROINNOVA 1. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae707
Authors:
Diego Ferone
Pamela Freda
Laurence Katznelson
Federico Gatto
Pinar Kadioğlu
Pietro Maffei
Jochen Seufert
Julie M Silverstein
Joanna L Spencer-Segal
Elena Isaeva
Alexander Dreval
Maria Harrie
Agneta Svedberg
Fredrik Tiberg
Affiliated Authors:
Pamela Freda
Author Keywords:
cam2029
fluidcrystal
acromegaly
octreotide
randomized controlled trial
somatostatin receptor ligands
Publication Type:
Article
Unique ID:
10.1210/clinem/dgae707
PMID:
Publication Date:
Data Source:
PubMed

Record Created: